Back | Next |
home / stock / pcsa / pcsa message board
Subject | By | Source | When |
---|---|---|---|
What do you make of this? | Big Brother | investorshub | 04/13/2023 1:29:39 PM |
$PCSA Price gaining up | Big Brother | investorshub | 04/12/2023 1:31:34 PM |
$PCSA MomentumIts trading | Renee | investorshub | 04/12/2023 12:46:27 PM |
$PCSA MomentumIts trading | Renee | investorshub | 04/11/2023 3:00:09 AM |
$PCSA MomentumIts now | $hellKing | investorshub | 04/11/2023 2:08:51 AM |
$PCSA Price gaining | Renee | investorshub | 04/10/2023 8:48:01 AM |
$PCSA MomentumIts now | parabol128 | investorshub | 04/09/2023 8:40:19 PM |
$PCSA bears are running | Renee | investorshub | 04/09/2023 8:22:08 PM |
$PCSA What do you make of this? | cash4 | investorshub | 04/09/2023 11:14:31 AM |
The trading up | Renee | investorshub | 04/08/2023 7:34:47 PM |
short squeeze article | crudeoil24 | investorshub | 04/07/2023 5:01:39 AM |
$PCSA MomentumIts now | cash4 | investorshub | 04/05/2023 6:24:47 PM |
Price now last trade up | Renee | investorshub | 04/05/2023 7:11:51 AM |
Price gaining | parabol128 | investorshub | 04/04/2023 4:05:31 PM |
what do you make of this data? | harry crumb | investorshub | 04/03/2023 8:46:05 AM |
Time for this to show some returns | $hellKing | investorshub | 04/02/2023 9:27:10 AM |
short squeeze all day | $hellKing | investorshub | 04/02/2023 12:51:27 AM |
$PCSA Do we have a winner?Turn around time? | Big Brother | investorshub | 04/01/2023 5:45:54 PM |
$PCSA what does this mean? | parabol128 | investorshub | 04/01/2023 7:41:30 AM |
MomentumIts trading | crudeoil24 | investorshub | 04/01/2023 2:49:45 AM |
News, Short Squeeze, Breakout and More Instantly...
Processa Pharmaceuticals Inc. Company Name:
PCSA Stock Symbol:
OTCMKTS Market:
Processa (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced positive efficacy results from the preliminary evaluation of its recently completed Phase 1b clinical trial. The...
Eight of 12 evaluable patients (66.7%) had progression-free survival (PFS) ranging from 5 to 11 months At the highest NGC-Cap dose, all three evaluable patients had PFS with two partial responses (PR) and one stable disease (SD) For all NGC-Cap doses, 5-Fluorouracil (5-FU) exp...
Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, will be represented at this month’s EF Hutton Annual Global Conference. According to the announcement, ke...